Jeffrey A Welge

Summary

Affiliation: University of Cincinnati
Country: USA

Publications

  1. ncbi request reprint Regression modeling of rodent locomotion data
    Jeffrey A Welge
    Department of Psychiatry, College of Medicine, University of Cincinnati, Cincinnati, OH 45267, USA
    Behav Brain Res 128:61-9. 2002
  2. ncbi request reprint Moderators of placebo response to antipsychotic treatment in patients with schizophrenia: a meta-regression
    Jeffrey A Welge
    Biological Psychiatry Program, Department of Psychiatry, University of Cincinnati College of Medicine, 231 Bethesda Avenue, P O Box 670559, Cincinnati, OH 45267 0559, USA
    Psychopharmacology (Berl) 166:1-10. 2003
  3. ncbi request reprint The dopamine D3 receptor antagonist NGB 2904 increases spontaneous and amphetamine-stimulated locomotion
    Laurel M Pritchard
    Department of Psychiatry, University of Cincinnati College of Medicine, 231 Albert Sabin Way, Cincinnati, OH 45267, USA
    Pharmacol Biochem Behav 86:718-26. 2007
  4. ncbi request reprint Altered behavioral response to dopamine D3 receptor agonists 7-OH-DPAT and PD 128907 following repetitive amphetamine administration
    Neil M Richtand
    Department of Psychiatry V 116A, Cincinnati Veterans Affairs Medical Center, Cincinnati, OH 45220, USA
    Neuropsychopharmacology 28:1422-32. 2003
  5. ncbi request reprint High-dose escitalopram in the treatment of binge-eating disorder with obesity: a placebo-controlled monotherapy trial
    Anna I Guerdjikova
    Division of Psychopharmacology Research, Department of Psychiatry, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267 0559, USA
    Hum Psychopharmacol 23:1-11. 2008
  6. doi request reprint Lamotrigine in the treatment of binge-eating disorder with obesity: a randomized, placebo-controlled monotherapy trial
    Anna I Guerdjikova
    Department of Psychiatry, University of Cincinnati College of Medicine, Lindner Center of HOPE, Mason, Ohio 45040, USA
    Int Clin Psychopharmacol 24:150-8. 2009
  7. pmc Analysis of a non-structural gene reveals evidence of possible hepatitis C virus (HCV) compartmentalization
    Jason T Blackard
    Division of Digestive Diseases, Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA
    J Med Virol 84:242-52. 2012
  8. ncbi request reprint A double-blind, placebo-controlled pilot study of quetiapine for depressed adolescents with bipolar disorder
    Melissa P DelBello
    Division of Bipolar Disorders Research, Department of Psychiatry, University of Cincinnati College of Medicine, 260 Stetson Street, Suite 3200, ML 559, Cincinnati, OH 45219, USA
    Bipolar Disord 11:483-93. 2009
  9. ncbi request reprint Atomoxetine in the treatment of binge-eating disorder: a randomized placebo-controlled trial
    Susan L McElroy
    Psychopharmacology Research Program, Department of Psychiatry, University of Cincinnati College of Medicine, OH 45267 0559, USA
    J Clin Psychiatry 68:390-8. 2007
  10. ncbi request reprint Placebo response in binge eating disorder: a pooled analysis of 10 clinical trials from one research group
    Thomas J Blom
    Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, OH, USA Lindner Center of HOPE, Mason, OH, USA
    Eur Eat Disord Rev 22:140-6. 2014

Research Grants

  1. Placebo Response in Patients with Schizophrenia
    Jeffrey Welge; Fiscal Year: 2003

Collaborators

Detail Information

Publications50

  1. ncbi request reprint Regression modeling of rodent locomotion data
    Jeffrey A Welge
    Department of Psychiatry, College of Medicine, University of Cincinnati, Cincinnati, OH 45267, USA
    Behav Brain Res 128:61-9. 2002
    ..Code for performing these analyses with standard statistical software is provided...
  2. ncbi request reprint Moderators of placebo response to antipsychotic treatment in patients with schizophrenia: a meta-regression
    Jeffrey A Welge
    Biological Psychiatry Program, Department of Psychiatry, University of Cincinnati College of Medicine, 231 Bethesda Avenue, P O Box 670559, Cincinnati, OH 45267 0559, USA
    Psychopharmacology (Berl) 166:1-10. 2003
    ..Therefore, it is of great importance to identify factors that moderate response to placebo in such trials...
  3. ncbi request reprint The dopamine D3 receptor antagonist NGB 2904 increases spontaneous and amphetamine-stimulated locomotion
    Laurel M Pritchard
    Department of Psychiatry, University of Cincinnati College of Medicine, 231 Albert Sabin Way, Cincinnati, OH 45267, USA
    Pharmacol Biochem Behav 86:718-26. 2007
    ..In combination, these data add to the behavioral profile of this novel D3 receptor ligand and provide further support for a role for dopamine D3 receptor inhibitory function in the modulation of rodent locomotion...
  4. ncbi request reprint Altered behavioral response to dopamine D3 receptor agonists 7-OH-DPAT and PD 128907 following repetitive amphetamine administration
    Neil M Richtand
    Department of Psychiatry V 116A, Cincinnati Veterans Affairs Medical Center, Cincinnati, OH 45220, USA
    Neuropsychopharmacology 28:1422-32. 2003
    ..These findings suggest a persistent release of D3 receptor-mediated inhibitory influence contributes to the expression of behavioral sensitization to amphetamine...
  5. ncbi request reprint High-dose escitalopram in the treatment of binge-eating disorder with obesity: a placebo-controlled monotherapy trial
    Anna I Guerdjikova
    Division of Psychopharmacology Research, Department of Psychiatry, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267 0559, USA
    Hum Psychopharmacol 23:1-11. 2008
    ..The purpose of this study was to evaluate the efficacy and safety of high-dose escitalopram in the treatment of binge-eating disorder (BED) associated with obesity...
  6. doi request reprint Lamotrigine in the treatment of binge-eating disorder with obesity: a randomized, placebo-controlled monotherapy trial
    Anna I Guerdjikova
    Department of Psychiatry, University of Cincinnati College of Medicine, Lindner Center of HOPE, Mason, Ohio 45040, USA
    Int Clin Psychopharmacol 24:150-8. 2009
    ..As a result of an exceptionally high placebo response, it is likely that for efficacy measures except for body weight and metabolic indices, the study was incapable of detecting potentially clinically important drug-placebo difference...
  7. pmc Analysis of a non-structural gene reveals evidence of possible hepatitis C virus (HCV) compartmentalization
    Jason T Blackard
    Division of Digestive Diseases, Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA
    J Med Virol 84:242-52. 2012
    ..Evidence of compartmentalization within a non-structural genomic region may suggest that viral adaptation to a unique extracellular microenvironment(s) may be required for efficient replication and could contribute to HCV persistence...
  8. ncbi request reprint A double-blind, placebo-controlled pilot study of quetiapine for depressed adolescents with bipolar disorder
    Melissa P DelBello
    Division of Bipolar Disorders Research, Department of Psychiatry, University of Cincinnati College of Medicine, 260 Stetson Street, Suite 3200, ML 559, Cincinnati, OH 45219, USA
    Bipolar Disord 11:483-93. 2009
    ..To conduct a pilot study comparing the effects of quetiapine and placebo for the treatment of depressive episodes in adolescents with bipolar I disorder...
  9. ncbi request reprint Atomoxetine in the treatment of binge-eating disorder: a randomized placebo-controlled trial
    Susan L McElroy
    Psychopharmacology Research Program, Department of Psychiatry, University of Cincinnati College of Medicine, OH 45267 0559, USA
    J Clin Psychiatry 68:390-8. 2007
    ..Binge-eating disorder (BED) is associated with obesity. Atomoxetine is a highly selective norepinephrine reuptake inhibitor associated with weight loss. The purpose of this study was to evaluate atomoxetine in the treatment of BED...
  10. ncbi request reprint Placebo response in binge eating disorder: a pooled analysis of 10 clinical trials from one research group
    Thomas J Blom
    Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, OH, USA Lindner Center of HOPE, Mason, OH, USA
    Eur Eat Disord Rev 22:140-6. 2014
    ..The aim of this study was to gain further understanding of placebo response in binge eating disorder...
  11. ncbi request reprint Citalopram in the treatment of binge-eating disorder: a placebo-controlled trial
    Susan L McElroy
    Division of Psychopharmacology Research and Eating Disorders, Department of Psychiatry, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267 0559, USA
    J Clin Psychiatry 64:807-13. 2003
    ..Citalopram is a highly selective serotonin reuptake inhibitor antidepressant. The purpose of this study was to assess the efficacy and safety of citalopram in the treatment of binge-eating disorder...
  12. pmc HIV mono-infection is associated with FIB-4 - A noninvasive index of liver fibrosis - in women
    Jason T Blackard
    Division of Digestive Disease, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA
    Clin Infect Dis 52:674-80. 2011
    ..FIB-4 represents a noninvasive, composite index that is a validated measure of hepatic fibrosis, which is an important indicator of liver disease. To date, there are limited data regarding hepatic fibrosis in women...
  13. ncbi request reprint Zonisamide in the treatment of binge eating disorder with obesity: a randomized controlled trial
    Susan L McElroy
    Psychopharmacology Research Program, Department of Psychiatry, University of Cincinnati College of Medicine, OH 45267 0559, USA
    J Clin Psychiatry 67:1897-906. 2006
    ..Binge eating disorder (BED) is associated with obesity. Zonisamide is a novel antiepileptic drug associated with weight loss. The purpose of this study was to evaluate zonisa-mide in the treatment of BED associated with obesity...
  14. pmc Conflict monitoring and adaptation in individuals at familial risk for developing bipolar disorder
    Luis R Patino
    Division of Bipolar Disorders Research, Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, OH 45219 0516, USA
    Bipolar Disord 15:264-71. 2013
    ..To examine conflict monitoring and conflict-driven adaptation in individuals at familial risk for developing bipolar disorder...
  15. pmc Risperidone pretreatment prevents elevated locomotor activity following neonatal hippocampal lesions
    Neil M Richtand
    Cincinnati Veterans Affairs Medical Center, Psychiatry Service V116A, Cincinnati, OH, USA
    Neuropsychopharmacology 31:77-89. 2006
    ..Additionally, these data support the use of low-dose risperidone in psychosis prevention, and suggest the possibility that higher risperidone doses could be less effective in this application...
  16. doi request reprint Glutamatergic effects of divalproex in adolescents with mania: a proton magnetic resonance spectroscopy study
    Jeffrey R Strawn
    University of Cincinnati, College of Medicine, Cincinnati, OH 45267, USA
    J Am Acad Child Adolesc Psychiatry 51:642-51. 2012
    ....
  17. ncbi request reprint Dopamine and serotonin receptor binding and antipsychotic efficacy
    Neil M Richtand
    Psychiatry Service, Cincinnati Veterans Affairs Medical Center, Cincinnati, OH, USA
    Neuropsychopharmacology 32:1715-26. 2007
    ..2) Increasing 5-HT(2C) and 5-HT(2A) receptor-binding affinities also facilitate antipsychotic efficacy. (3) Increasing 5-HT(1A) receptor-binding affinity, in contrast, reduces antipsychotic efficacy...
  18. ncbi request reprint Gabapentin in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled, multicenter trial
    Lesley M Arnold
    University of Cincinnati College of Medicine, Cincinnati, Ohio 45219, and Newton Wellesley Hospital, Newton, MA, USA
    Arthritis Rheum 56:1336-44. 2007
    ..To assess the efficacy and safety of gabapentin in patients with fibromyalgia...
  19. ncbi request reprint Olanzapine in the treatment of pathological gambling: a negative randomized placebo-controlled trial
    Susan L McElroy
    Psychopharmacology Research Program, Department of Psychiatry, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267 0559, USA
    J Clin Psychiatry 69:433-40. 2008
    ..Olanzapine is a second-generation antipsychotic with mood-stabilizing properties and antagonistic activity at several dopamine receptors. The purpose of this study was to evaluate olanzapine in the treatment of pathological gambling...
  20. ncbi request reprint Role of serotonin and dopamine receptor binding in antipsychotic efficacy
    Neil M Richtand
    Cincinnati Veterans Affairs Medical Center, 3200 Vine Street, ML0559, Cincinnati, OH 45220, USA
    Prog Brain Res 172:155-75. 2008
    ....
  21. ncbi request reprint Risk and protective factors associated with substance use disorders in adolescents with first-episode mania
    Jacob R Stephens
    Research, Observation, Service, Education ROSE Program and the Division of Bipolar Disorders Research, University of Cincinnati College of Medicine, Cincinnati, OH
    J Am Acad Child Adolesc Psychiatry 53:771-9. 2014
    ..The purpose of this study was to identify predictors of developing SUDs after a first manic episode...
  22. pmc Relative expression of D3 dopamine receptor and alternative splice variant D3nf mRNA in high and low responders to novelty
    Laurel M Pritchard
    Department of Psychiatry, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA
    Brain Res Bull 70:296-303. 2006
    ..Additionally, these findings are consistent with the hypothesis that alternative splicing may contribute to regulation of D3 dopamine receptor function...
  23. ncbi request reprint A double-blind randomized pilot study comparing quetiapine and divalproex for adolescent mania
    Melissa P DelBello
    Department of Psychiatry, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267 0559, USA
    J Am Acad Child Adolesc Psychiatry 45:305-13. 2006
    ..To determine the comparative efficacy of quetiapine and divalproex for the treatment of adolescent mania...
  24. doi request reprint Development and testing of the fibromyalgia diagnostic screen for primary care
    Lesley M Arnold
    University of Cincinnati College of Medicine, Cincinnati, OH 45219, USA
    J Womens Health (Larchmt) 21:231-9. 2012
    ..The Fibromyalgia Diagnostic Screen was developed for use by primary care clinicians to assist in the diagnostic evaluation of fibromyalgia, a disorder that predominantly affects women...
  25. doi request reprint Hepatitis B virus (HBV) X gene diversity and evidence of recombination in HBV/HIV co-infected persons
    Christina M Martin
    Division of Digestive Diseases, Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA
    J Med Virol 83:1142-50. 2011
    ..Recombination between HBV genotypes may represent an important evolutionary strategy that enhances overall pathogenic potential and/or alters the downstream effects of the HBV X protein...
  26. ncbi request reprint Genotype and smoking history affect risk of levodopa-induced dyskinesias in Parkinson's disease
    Judith A Strong
    Department of Cell Biology, Neurobiology, and Anatomy, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267, USA
    Mov Disord 21:654-9. 2006
    ..Our results suggest that smoking history may also influence the response to levodopa, with contribution comparable to those of individual genes including the mu opioid receptor and D2 dopamine receptor...
  27. ncbi request reprint A randomized, placebo-controlled, double-blind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia
    Lesley M Arnold
    Women s Health Research Program, Department of Psychiatry, University of Cincinnati Medical Center, Cincinnati, Ohio 45267 0559, USA
    Am J Med 112:191-7. 2002
    ..To assess the efficacy of fluoxetine in the treatment of patients with fibromyalgia...
  28. ncbi request reprint Venlafaxine treatment of binge-eating disorder associated with obesity: a series of 35 patients
    Shishuka Malhotra
    Department of Psychiatry, University of Cincinnati Medical Center, Ohio 45267 0559, USA
    J Clin Psychiatry 63:802-6. 2002
    ....
  29. pmc Cytokine expression during chronic versus occult hepatitis B virus infection in HIV co-infected individuals
    Christina M Martin
    Department of Internal Medicine, Division of Digestive Diseases, University of Cincinnati College of Medicine, OH 45267, USA
    Cytokine 47:194-8. 2009
    ....
  30. pmc Functional magnetic resonance imaging brain activation in bipolar mania: evidence for disruption of the ventrolateral prefrontal-amygdala emotional pathway
    Stephen M Strakowski
    Division of Bipolar Disorders Research, Department of Psychiatry, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267 0559 USA
    Biol Psychiatry 69:381-8. 2011
    ..We used functional magnetic resonance imaging (fMRI) to study manic bipolar subjects as they performed a cognitive task designed to examine the ventrolateral prefrontal emotional arousal network...
  31. ncbi request reprint Use of standardized patients during a psychiatry clerkship
    Aurora J Bennett
    University of Cincinnati, 222 Piedmont Ave, Medical Arts Building, Ste 8500, Cincinnati, Ohio 45219, USA
    Acad Psychiatry 30:185-90. 2006
    ....
  32. ncbi request reprint Predictors of response to treatment of acute bipolar manic episodes with divalproex sodium or placebo in 2 randomized, controlled, parallel-group trials
    Jeffrey A Welge
    Division of Clinical Neuroscience, Psychopharmacology Research Program, Department of Psychiatry, University of Cincinnati College of Medicine, Cincinnati Veterans Affairs Medical Center, Cincinnati, OH, USA
    J Clin Psychopharmacol 24:607-12. 2004
    ..Stratification on the basis of these prognostic factors may improve the power of future trials for the treatment of acute mania and may help explain patient response to treatment...
  33. ncbi request reprint Psychiatric and legal features of 113 men convicted of sexual offenses
    Neal W Dunsieth
    Center for the Study of Criminal Behavior, Department of Psychiatry, University of Cincinnati College of Medicine, 231 Albert Sabin Way, Cincinnati, OH 45267 0559, USA
    J Clin Psychiatry 65:293-300. 2004
    ..To increase understanding of the relationships among sexual violence, paraphilias, and mental illness, the authors assessed the legal and psychiatric features of 113 men convicted of sexual offenses...
  34. ncbi request reprint Parathyroid adenoma localization: surgeon-performed ultrasound versus sestamibi
    David L Steward
    Department of Otolaryngology Head and Neck Surgery, University of Cincinnati, Cincinnati, OH 45267, USA
    Laryngoscope 116:1380-4. 2006
    ..Compare surgeon-performed ultrasound versus sestamibi for preoperative parathyroid adenoma localization...
  35. ncbi request reprint 7-OH-DPAT and PD 128907 selectively activate the D3 dopamine receptor in a novel environment
    Laurel M Pritchard
    Department of Cell Biology, Neurobiology and Anatomy, University of Cincinnati, OH, USA
    Neuropsychopharmacology 28:100-7. 2003
    ..Potential implications of these observations are discussed...
  36. ncbi request reprint Steroids for post-tonsillectomy pain reduction: meta-analysis of randomized controlled trials
    Chad E Afman
    Department of Otolaryngology Head and Neck Surgery, University of Cincinnati, Cincinnati, Ohio, USA
    Otolaryngol Head Neck Surg 134:181-6. 2006
    ..To determine whether meta-analysis supports the use of corticosteroids to reduce post-tonsillectomy pain for pediatric patients...
  37. pmc Variability of the polymerase gene (NS5B) in hepatitis C virus-infected women
    Jason T Blackard
    Department of Internal Medicine, Division of Digestive Diseases, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267, USA
    J Clin Microbiol 48:4256-9. 2010
    ..Moreover, differences between NS5B nonsynonymous (dN) and synonymous (dS) mutation rates (dN - dS) were positively correlated with CD4 cell count, while nonsynonymous mutations were strongly correlated with reduced replication in vivo...
  38. ncbi request reprint Efficacy of inactivated hepatitis A vaccine in HIV-infected patients: a hierarchical bayesian meta-analysis
    Norah J Shire
    College of Medicine, University of Cincinnati, 231 Albert Sabin Way, ML 0595, Cincinnati, OH 45267, USA
    Vaccine 24:272-9. 2006
    ..The overall response rate to HAV vaccine in HIV-infected patients is lower than typically cited. Up to 1/2 of HIV-infected patients may be nonresponders. Future research will be required to better understand the correlates of response...
  39. pmc Heterogeneity of neuroendocrine stress responses in aging rat strains
    Tracy M Segar
    University of Cincinnati, Department of Psychiatry, Cincinnati, OH 45237, USA
    Physiol Behav 96:6-11. 2009
    ..The results suggest that these older rat strains may be useful models to further assess individual differences in neuroendocrine aging...
  40. pmc HIV infection of hepatocytes results in a modest increase in hepatitis C virus expression in vitro
    Ling Kong
    Division of Digestive Diseases, Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio, United States of America
    PLoS ONE 9:e83728. 2014
    ..These findings suggest that HIV suppression may be a critical factor in controlling liver disease, particularly if the underlying liver disease is not treated. ..
  41. pmc Therapeutic paralysis in veterans with COPD
    Aaron M Mulhall
    Department of Internal Medicine, University of Cincinnati Academic Health Center, 231 Albert Sabin Way, Cincinnati, OH 45267, USA Electronic address
    Respir Med 107:1547-57. 2013
    ..To measure Veterans' perceptions about COPD, the effect of COPD on their lives and health, and their needs for improved health, we performed a postal survey...
  42. doi request reprint Alcohol expectancies and social self-efficacy as mediators of differential intervention outcomes for college hazardous drinkers with social anxiety
    Jessica J Black
    Department of Psychology, University of Cincinnati, Cincinnati, OH 45221 0376, United States
    Addict Behav 37:248-55. 2012
    ..Study results may enhance the understanding of cognitive factors' role in alcohol treatment outcomes, which could in turn improve the efficacy of interventions aimed to reduce hazardous drinking and comorbid social anxiety...
  43. ncbi request reprint A placebo-controlled, randomized trial of fluoxetine in the treatment of binge-eating disorder
    Lesley M Arnold
    Women s Health Research Program, Department of Psychiatry, University of Cincinnati Medical Center, Cincinnati, Ohio, USA
    J Clin Psychiatry 63:1028-33. 2002
    ..The purpose of this study was to assess the efficacy and safety of fluoxetine in the treatment of binge-eating disorder...
  44. ncbi request reprint Efficacy of thyroid hormone suppression for benign thyroid nodules: meta-analysis of randomized trials
    Matthew T Sdano
    Department of Otolaryngology Head and Neck Surgery, University of Cincinnati College of Medicine, OH 45267, USA
    Otolaryngol Head Neck Surg 133:391-6. 2005
    ..To determine the efficacy of thyroid hormone suppressive therapy (THST) to decrease benign thyroid nodule volume...
  45. ncbi request reprint Characterization of the distribution of the cocaine priming threshold and the effect of SCH23390
    Andrew B Norman
    Department of Psychiatry, Division of Neuroscience, University of Cincinnati, College of Medicine, P O Box 670559, OH 45267 0559, USA
    Brain Res 946:253-61. 2002
    ..This technique provides a quantitative method for the measurement of antagonist-induced increases in the cocaine priming threshold...
  46. ncbi request reprint Olanzapine versus placebo in acute mania: treatment responses in subgroups
    Ross J Baldessarini
    International Consortium for Bipolar Disorder Research, Department of Psychiatry and Neuroscience Program, Harvard Medical School, Boston, MA, USA
    J Clin Psychopharmacol 23:370-6. 2003
    ..5-1.7, all P < 0.01). These well-powered comparisons of subgroups of interest indicate broad efficacy of olanzapine in the treatment of acute mania...
  47. ncbi request reprint Atypical antipsychotics in the treatment of mania: a meta-analysis of randomized, placebo-controlled trials
    Roy H Perlis
    Bipolar Research Program, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA
    J Clin Psychiatry 67:509-16. 2006
    ..However, there are no published comparisons of individual atypical antipsychotics for mania...
  48. ncbi request reprint Effect of divalproex sodium on behavioural and cognitive problems in elderly dementia
    Jane M Meinhold
    Department of Neuroscience, Abbott Laboratories, Abbott Park, Illinois 60064, USA
    Drugs Aging 22:615-26. 2005
    ..The antiepileptic agent divalproex sodium may have advantages in this setting because of lower rates of drug interactions and adverse effects in this patient population...
  49. ncbi request reprint Clinical comparison of extended-release divalproex versus delayed-release divalproex: pooled data analyses from nine trials
    Michael C Smith
    Rush Epilepsy Center, Rush Presbyterian St Luke s Medical Center, Chicago, IL, USA
    Epilepsy Behav 5:746-51. 2004
    ..Although the results of the current analyses must be considered highly tentative due to the open-label nature of the trials included, the findings do suggest broad clinical superiority of the new ER preparation...
  50. ncbi request reprint The prevalence of the metabolic syndrome in psychiatric inpatients with primary psychotic and mood disorders
    Richard A Bermudes
    Department of Psychiatry and Behavioral Sciences, UC Davis Medical Center, Sacramento, CA 95817 1419, USA
    Psychosomatics 47:491-7. 2006
    ....

Research Grants1

  1. Placebo Response in Patients with Schizophrenia
    Jeffrey Welge; Fiscal Year: 2003
    ..We hypothesize that duration of placebo treatment, duration of illness, and baseline symptom severity will be among the factors that determine response to placebo. ..